Investor Overview
SKVI trading Exclusively on OTCQB
To get a SKVI quote today, click here:
http://www.otcmarkets.com/stock/SKVI/quote
IMPORTANT: The OTCQB inter-dealer quotation system is interlinked with most financial websites but we encourage you to look at other sites if you do not see a current quote. All financial websites should be up-to-date in the near future.
Shareholder's Information:
Shares Outstanding Are: 4,471,746 (as of Oct 25, 2019)
Authorized Shares: 200,000,000
Fiscal Year End: December 31
February 14, 2024
Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome
June 6, 2022
Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New Drug Application
February 13, 2020
Skinvisible Announces License Agreement
October 22, 2019
Skinvisible Announces Worldwide License Agreement with Quoin Pharmaceuticals in Conjunction with Mutual Termination of Merger Agreement
January 8, 2019
Skinvisible Update to Shareholders Re Merger and Reverse Split
|
Stock Information:
SEC Filings
SKVI quote
Press Releases
Sign up for Skinvisible Inc. Updates:
Click here to join our mailing list.
|